Please login to the form below
cancer
This page shows the latest cancer news and features for those working in and with pharma, biotech and healthcare.
Roche pulls EU Tecentriq/Avastin filing in kidney cancer
Roche pulls EU Tecentriq/Avastin filing in kidney cancer. Another setback for Roche, but CHMP changes its mind on Opdivo/Yervoy. ... little longer before it can bring it forward for RCC, the most common form of kidney cancer.
Latest news
-
Roche builds on Immunocore ImmTAC deal
The trial is scheduled to start in early 2019, and will include a host of cancers, including non-small cell lung cancer (NSCLC), bladder cancer, head and neck cancer, gastric cancer ... Those molecules are based on soluble, engineered TCR’s, which
-
CHMP backs Sanofi’s all-oral sleeping sickness drug
Johnson &Johnson got a positive opinion on its non-metastatic castration-resistant prostate cancer (CRPC) drug Erleada (apalutamide), setting up EU approval to follow its FDA green light earlier in the ... Among these, Novartis’CDK4/6 inhibitor Kisqali
-
AZ’s MYSTIC survival data is in – and it’s a bust
Imfinzi failed to achieve OS improvement. AstraZeneca has released the overall survival (OS) data from its MYSTIC trial of Imfinzi and tremelimumab in advanced non-small cell lung cancer (NSCLC), and ... In the meantime, AZ also has trials of Imfinzi
-
AZ drug matched to cancer mutation passes phase 2 test
AZ drug matched to cancer mutation passes phase 2 test. More data from promising class of targeted small molecule drugs. ... AKT E17K is present in about 1% of all tumours and is particularly common in prostate cancer.
-
Roche’s Genetech nabs speedy review for Tecentriq in first-line breast cancer
Roche’ s Genetech nabs speedy review for Tecentriq in first-line breast cancer. ... Tecentriq in combination with nab-paclitaxel has the potential to meaningfully advance treatment for people with PD-L1-positive, metastatic triple-negative breast cancer
More from news
Approximately 646 fully matching, plus 1,612 partially matching documents found.
Latest Intelligence
-
The handover: Pfizer reshapes itself for a new era
Innovative health revenue increased 4% to $8.47bn, lifted by sales of blood thinner Eliquis and breast cancer drug Ibrance outside the US, among others. ... Breast cancer drug Ibrance will be one of the biggest growth drivers for the company, as it looks
-
Lonely planet: why there is dwindling value in pharma travelling alone
All.Can was established to identify ways of optimising the efficiency of cancer care to improve outcomes. ... across the cancer care continuum.”.
-
Making Europe a leader in bioscience: boosting trust and opening minds
This public-private research alliance is aimed at improving survival rates in hepatocellular carcinoma (the primary cancer of the liver). ... of this cancer.
-
Cancer care – the power of new technologies
Last month marked the publication of the seventh NHS England’s annual National Cancer Patient Experience Survey. ... As people are living longer, more and more people will be living longer with cancer.
-
AstraZeneca: building a new ‘open innovation’ pharma company
Open-minded culture. Like the new HQ’s construction, there have been setbacks – such as the failure of two immunotherapies in the MYSTIC lung cancer trial last year – but the company ... The park is also home to the Cancer Research UK Institute, a
More from intelligence
Approximately 8 fully matching, plus 245 partially matching documents found.
Latest appointments
-
Ipsen hires general manager, Laura Hamill joins Gilead and Orchard expands leadership team
There he oversaw the oncology-focused company's launch in the region, as well as the launch and UK reimbursement of its PARP inhibitor in recurrent ovarian cancer.
-
BMS appoints CCO, Stephen Davies joins Eisai and more
Apeiron expands board. Cancer Immunotherapy company Apeiron has expanded its board, appointing Anderson Gaweco as its chief medical and scientific officer. ... class new treatments for cancer patients and to help transform the company into a world-class
-
Marinomed appoints CFO, Robin Brown is named chair of Medicines Discovery Catapult, Filippo Petti joins Ceylad and Vivienne Fox to chair RFI
He said: “Celyad’s differentiated approach to the field of CAR-T cell therapy could lead to a meaningful impact on the lives of patients battling a broad array of cancers.
-
Industry appointments
As a result, I joined Zelluna because I believe these TCRs provide opportunities for driving differentiated therapeutic benefits in patients fighting solid cancers.”. ... In the longer term, Hassan will lead research activities with the aim to expand
-
Sue Mahony to retire as president of Lilly Oncology
We make medicines that help patients with cancer live longer and what a privilege it’s been to wake up each morning with that as my life’s work.”.
More from appointments
Approximately 5 fully matching, plus 199 partially matching documents found.
Latest from PMHub
-
Porterhouse Medical is raising awareness for pancreatic cancer, here’s why…
Porterhouse Medical is raising awareness for pancreatic cancer, here’ s why….
-
Pet Cancer Therapeutics Market to Soar at 10% CAGR to 2024
Growing adoption of pets around the world has fueled the Pet Cancer Therapeutics market growth, as pet cats and dogs are highly susceptible to developing cancers that can be solely treated ... U.S. pet cancer therapeutics market holds the largest revenue
-
Carcinoembryonic Antigen (CEA) Market Intelligence Research Reports for Actionable Insights
The test is also used to manage and diagnose certain types of cancers like breast cancer, colorectal or colon cancer, cancer of the gastrointestinal tract, liver cancer, ovarian cancer, lung cancer ... demand for minimally invasive diagnostic procedures
-
Palliative Care Market Intelligence Study for Comprehensive Insights
Palliative care is provided to patients suffering from diseases such as cancer, congestive heart failure (CHF), CNS disorders, chronic pulmonary obstructive disease (COPD) and others, providing symptomatic relief for nausea &vomiting, ... Majority of
-
Radiotherapy Market | Global Industry Analysis, Segments, Top Key Players, Drivers and Trends to 2023
Radiation therapy is synergistic with chemotherapy, and has been used before, during, and after chemotherapy in susceptible cancers. ... Lung Cancer. Cervical Cancer. Others. Request a discount on standard prices of this premium report titled at:.
More from PMHub
Approximately 38 fully matching, plus 216 partially matching documents found.
Featured jobs
-
Medical/ Scientific Director
-
Salary TBC
- Leadership opportunity, Pricing & Market Access, UK, Substan...
-
Substantial six figure package
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
- Director, Market Access / HEOR - North-West
-
Negotiable
- Senior Systematic Review Analyst - Oxford
-
Negotiable
-
Senior Medical Writer
-
Competitive Salary
-
Account Manager / Account Director
-
Competative
-
Senior Medical Writer
-
Great salary and benefits
- Senior Account Managers - Oxfordshire
-
Attractive salary and benefits package offered
-
Account Director
-
Excellent benefits
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
-
Associate Medical Director
-
Highly Competitive
- Account Manager / Senior Account Manager
-
35, 000-40, 000
- Senior Medical Writer (Remote Working)
-
Competitive Salary Offered
- Events Manager – Med Comms – Surrey
-
Salary TBC
- Scientific Director – Medical Communications - New York or Remot...
-
$100000 - $150000
-
Account Director
-
£48, 000 - £60, 000
Subscribe to our email news alerts
- Medical Oxygen Concentrators Market Expected to Behold a CAGR of 8.9% During 2018 – 2024
- Breast Cancer Therapeutics Market Projected to Register 9% CAGR to 2024
- Oxygen Cylinders and Concentrators Market to Grow at over 9.8% CAGR to 2024 | Inogen, Tecno Gaz, Koninklijke Philips N.V
- Clinical Trial Management Systems Market Projected to Register 13% CAGR to 2024
- Steam Autoclaves Market is expected to witness more than 8.5% CAGR from 2018 to 2024
- Smart Contact Lens Market Analysis By Application, Size, Growth, Demand & Forecast - 2026
PMHub
infill healthcare communication
infill is a dynamic and innovative, international healthcare agency with >25 years' experience in delivering healthcare communication, medical education and...
Latest intelligence
- OUTiCO win Best in UK Pharmaceutical Outsourcing award
- The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
- Artificial Intelligence in Healthcare
- Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
- World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
- Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...
Quick links
Infographics
